Cargando…
In vitro and in silico studies of bis (indol-3-yl) methane derivatives as potential α-glucosidase and α-amylase inhibitors
In this paper, bis (indol-3-yl) methanes (BIMs) were synthesised and evaluated for their inhibitory activity against α-glucosidase and α-amylase. All synthesised compounds showed potential α-glucosidase and α-amylase inhibitory activities. Compounds 5 g (IC(50): 7.54 ± 1.10 μM), 5e (IC(50): 9.00 ± 0...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409970/ https://www.ncbi.nlm.nih.gov/pubmed/34459690 http://dx.doi.org/10.1080/14756366.2021.1971976 |
_version_ | 1783747068322381824 |
---|---|
author | Zheng, Peng-Fei Xiong, Zhuang Liao, Cui-ying Zhang, Xin Feng, Mei Wu, Xiao-Zheng Lin, Jing Lei, Lin-Sheng Zhang, You-Cheng Wang, Shao-Hua Xu, Xue-Tao |
author_facet | Zheng, Peng-Fei Xiong, Zhuang Liao, Cui-ying Zhang, Xin Feng, Mei Wu, Xiao-Zheng Lin, Jing Lei, Lin-Sheng Zhang, You-Cheng Wang, Shao-Hua Xu, Xue-Tao |
author_sort | Zheng, Peng-Fei |
collection | PubMed |
description | In this paper, bis (indol-3-yl) methanes (BIMs) were synthesised and evaluated for their inhibitory activity against α-glucosidase and α-amylase. All synthesised compounds showed potential α-glucosidase and α-amylase inhibitory activities. Compounds 5 g (IC(50): 7.54 ± 1.10 μM), 5e (IC(50): 9.00 ± 0.97 μM), and 5 h (IC(50): 9.57 ± 0.62 μM) presented strongest inhibitory activities against α-glucosidase, that were ∼ 30 times stronger than acarbose. Compounds 5 g (IC(50): 32.18 ± 1.66 µM), 5 h (IC(50): 31.47 ± 1.42 µM), and 5 s (IC(50): 30.91 ± 0.86 µM) showed strongest inhibitory activities towards α-amylase, ∼ 2.5 times stronger than acarbose. The mechanisms and docking simulation of the compounds were also studied. Compounds 5 g and 5 h HIGHLIGHTS: 1. A series of bis (indol-3-yl) methanes (BIMs) were synthesised and evaluated inhibitory activities against α-glucosidase and α-amylase. 2. Compound 5g exhibited promising activity (IC(50) = 7.54 ± 1.10 μM) against α-glucosidase. 3. Compound 5s exhibited promising activity (IC(50) = 30.91 ± 0.86 μM) against α-amylase. 4. In silico studies were performed to confirm the binding interactions of synthetic compounds with the enzyme active site. |
format | Online Article Text |
id | pubmed-8409970 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-84099702021-09-02 In vitro and in silico studies of bis (indol-3-yl) methane derivatives as potential α-glucosidase and α-amylase inhibitors Zheng, Peng-Fei Xiong, Zhuang Liao, Cui-ying Zhang, Xin Feng, Mei Wu, Xiao-Zheng Lin, Jing Lei, Lin-Sheng Zhang, You-Cheng Wang, Shao-Hua Xu, Xue-Tao J Enzyme Inhib Med Chem Research Paper In this paper, bis (indol-3-yl) methanes (BIMs) were synthesised and evaluated for their inhibitory activity against α-glucosidase and α-amylase. All synthesised compounds showed potential α-glucosidase and α-amylase inhibitory activities. Compounds 5 g (IC(50): 7.54 ± 1.10 μM), 5e (IC(50): 9.00 ± 0.97 μM), and 5 h (IC(50): 9.57 ± 0.62 μM) presented strongest inhibitory activities against α-glucosidase, that were ∼ 30 times stronger than acarbose. Compounds 5 g (IC(50): 32.18 ± 1.66 µM), 5 h (IC(50): 31.47 ± 1.42 µM), and 5 s (IC(50): 30.91 ± 0.86 µM) showed strongest inhibitory activities towards α-amylase, ∼ 2.5 times stronger than acarbose. The mechanisms and docking simulation of the compounds were also studied. Compounds 5 g and 5 h HIGHLIGHTS: 1. A series of bis (indol-3-yl) methanes (BIMs) were synthesised and evaluated inhibitory activities against α-glucosidase and α-amylase. 2. Compound 5g exhibited promising activity (IC(50) = 7.54 ± 1.10 μM) against α-glucosidase. 3. Compound 5s exhibited promising activity (IC(50) = 30.91 ± 0.86 μM) against α-amylase. 4. In silico studies were performed to confirm the binding interactions of synthetic compounds with the enzyme active site. Taylor & Francis 2021-08-30 /pmc/articles/PMC8409970/ /pubmed/34459690 http://dx.doi.org/10.1080/14756366.2021.1971976 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Zheng, Peng-Fei Xiong, Zhuang Liao, Cui-ying Zhang, Xin Feng, Mei Wu, Xiao-Zheng Lin, Jing Lei, Lin-Sheng Zhang, You-Cheng Wang, Shao-Hua Xu, Xue-Tao In vitro and in silico studies of bis (indol-3-yl) methane derivatives as potential α-glucosidase and α-amylase inhibitors |
title | In vitro and in silico studies of bis (indol-3-yl) methane derivatives as potential α-glucosidase and α-amylase inhibitors |
title_full | In vitro and in silico studies of bis (indol-3-yl) methane derivatives as potential α-glucosidase and α-amylase inhibitors |
title_fullStr | In vitro and in silico studies of bis (indol-3-yl) methane derivatives as potential α-glucosidase and α-amylase inhibitors |
title_full_unstemmed | In vitro and in silico studies of bis (indol-3-yl) methane derivatives as potential α-glucosidase and α-amylase inhibitors |
title_short | In vitro and in silico studies of bis (indol-3-yl) methane derivatives as potential α-glucosidase and α-amylase inhibitors |
title_sort | in vitro and in silico studies of bis (indol-3-yl) methane derivatives as potential α-glucosidase and α-amylase inhibitors |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409970/ https://www.ncbi.nlm.nih.gov/pubmed/34459690 http://dx.doi.org/10.1080/14756366.2021.1971976 |
work_keys_str_mv | AT zhengpengfei invitroandinsilicostudiesofbisindol3ylmethanederivativesaspotentialaglucosidaseandaamylaseinhibitors AT xiongzhuang invitroandinsilicostudiesofbisindol3ylmethanederivativesaspotentialaglucosidaseandaamylaseinhibitors AT liaocuiying invitroandinsilicostudiesofbisindol3ylmethanederivativesaspotentialaglucosidaseandaamylaseinhibitors AT zhangxin invitroandinsilicostudiesofbisindol3ylmethanederivativesaspotentialaglucosidaseandaamylaseinhibitors AT fengmei invitroandinsilicostudiesofbisindol3ylmethanederivativesaspotentialaglucosidaseandaamylaseinhibitors AT wuxiaozheng invitroandinsilicostudiesofbisindol3ylmethanederivativesaspotentialaglucosidaseandaamylaseinhibitors AT linjing invitroandinsilicostudiesofbisindol3ylmethanederivativesaspotentialaglucosidaseandaamylaseinhibitors AT leilinsheng invitroandinsilicostudiesofbisindol3ylmethanederivativesaspotentialaglucosidaseandaamylaseinhibitors AT zhangyoucheng invitroandinsilicostudiesofbisindol3ylmethanederivativesaspotentialaglucosidaseandaamylaseinhibitors AT wangshaohua invitroandinsilicostudiesofbisindol3ylmethanederivativesaspotentialaglucosidaseandaamylaseinhibitors AT xuxuetao invitroandinsilicostudiesofbisindol3ylmethanederivativesaspotentialaglucosidaseandaamylaseinhibitors |